Si Bone, Inc. SIBN
We take great care to ensure that the data presented and summarized in this overview for SI-BONE, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SIBN
View all-
Black Rock Inc. New York, NY3.85MShares$58.5 Million0.0% of portfolio
-
Brown Advisory Inc2.91MShares$44.3 Million0.08% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.58MShares$39.2 Million1.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$37.2 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.32MShares$35.2 Million0.02% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.14MShares$32.5 Million0.3% of portfolio
-
First Light Asset Management, LLC Edina, MN1.75MShares$26.6 Million5.07% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY1.48MShares$22.5 Million0.19% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.26MShares$19.2 Million1.13% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL1.26MShares$19.2 Million0.01% of portfolio
Latest Institutional Activity in SIBN
Top Purchases
Top Sells
About SIBN
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Insider Transactions at SIBN
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 08
2025
|
John Gordon Freund |
SELL
Open market or private sale
|
Indirect |
12,132
-11.68%
|
$181,980
$15.99 P/Share
|
Aug 04
2025
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
293
-2.45%
|
$4,981
$17.37 P/Share
|
Jul 07
2025
|
Laura Francis Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
757
-0.21%
|
$13,626
$18.26 P/Share
|
Jul 02
2025
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
3,310
-0.59%
|
$59,580
$18.27 P/Share
|
Jul 02
2025
|
Anshul Maheshwari Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,005
-0.76%
|
$90,090
$18.34 P/Share
|
Jul 02
2025
|
Michael A Pisetsky SVP, Ops & Adm/Chief Legal Ofr |
SELL
Open market or private sale
|
Direct |
3,127
-0.39%
|
$56,286
$18.32 P/Share
|
Jun 05
2025
|
Gregory K Hinckley |
BUY
Grant, award, or other acquisition
|
Direct |
8,675
+7.83%
|
-
|
Jun 05
2025
|
Jeryl L Hilleman |
BUY
Grant, award, or other acquisition
|
Direct |
8,675
+20.91%
|
-
|
Jun 05
2025
|
Mika Nishimura |
BUY
Grant, award, or other acquisition
|
Direct |
8,675
+19.07%
|
-
|
Jun 05
2025
|
Thomas A. West |
BUY
Grant, award, or other acquisition
|
Direct |
8,675
+24.32%
|
-
|
Jun 05
2025
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct |
3,377
-16.29%
|
$64,163
$19.05 P/Share
|
Jun 05
2025
|
Jeffrey W Dunn |
BUY
Grant, award, or other acquisition
|
Direct |
8,675
+29.03%
|
-
|
Jun 05
2025
|
Daniel W Wolf |
BUY
Grant, award, or other acquisition
|
Direct |
8,675
+25.12%
|
-
|
Jun 05
2025
|
Timothy E Davis Jr |
BUY
Grant, award, or other acquisition
|
Direct |
8,675
+12.46%
|
-
|
Jun 05
2025
|
John Gordon Freund |
BUY
Grant, award, or other acquisition
|
Direct |
8,675
+16.69%
|
-
|
May 19
2025
|
Anshul Maheshwari Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,424
-1.08%
|
$46,056
$19.48 P/Share
|
May 19
2025
|
Laura Francis Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,412
-1.09%
|
$102,828
$19.49 P/Share
|
May 16
2025
|
Michael A Pisetsky SVP, Ops & Adm/Chief Legal Ofr |
SELL
Open market or private sale
|
Direct |
3,459
-0.43%
|
$65,721
$19.51 P/Share
|
May 16
2025
|
Anthony J Recupero President, Commercial Ops |
SELL
Open market or private sale
|
Direct |
4,147
-0.29%
|
$78,793
$19.67 P/Share
|
May 16
2025
|
Anshul Maheshwari Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,585
-0.6%
|
$182,115
$19.69 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 487K shares |
---|---|
Exercise of conversion of derivative security | 21.4K shares |
Open market or private sale | 279K shares |
---|